Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 7,859 | 0.0% | 118,372 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 3,586 | 0.0% | 103,982 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,643 | 0.0% | 103,976 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,308 | 0.0% | 102,675 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,977 | 0.0% | 105,154 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 2,059 | 0.0% | 106,293 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 3,136 | 0.0% | 120,675 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 3,503 | 0.0% | 122,486 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 3,285 | 0.0% | 107,350 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,013 | 0.0% | 112,133 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 4,445 | 0.0% | 124,645 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 3,220 | 0.0% | 126,766 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 5,221 | 0.0% | 128,734 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 4,200 | 0.0% | 127,079 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,554 | 0.0% | 129,331 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 5,919 | 0.0% | 128,693 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 9,216 | 0.0% | 139,007 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 8,476 | 0.0% | 135,775 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 11,569 | 0.0% | 139,693 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 10,239 | 0.0% | 154,410 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 11,649 | 0.0% | 151,823 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 6,542 | 0.0% | 151,921 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 6,537 | 0.0% | 151,348 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 4,378 | 0.0% | 152,160 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 9,047 | 0.0% | 142,624 | 12/31/2019 |